Vaccine News and Research

Latest Vaccine News and Research

Malaria parasite employs active strategy to deceive the immune system

Global efforts to eradicate malaria are crucially dependent on scientists' ability to outsmart the malaria parasite. And Plasmodium falciparum is notoriously clever: It is quick to develop resistance against medications and has such a complex life cycle that blocking it effectively with a vaccine has thus far proved elusive.

7 Dec 2017

Investigational ZPIV vaccine found to be safe and immunogenic in trial participants

The investigational Zika purified inactivated virus (ZPIV) vaccine was well-tolerated and induced an immune response in participants, according to initial results from three Phase 1 clinical trials.

5 Dec 2017

ICG provides 1.4 million vaccine doses to control yellow fever outbreak in Nigeria

The International Coordinating Group on vaccine provision for yellow fever has provided 1.4 million vaccine doses for an immunization campaign that starts on Saturday (2 December) to help control an ongoing yellow fever outbreak in Nigeria.

5 Dec 2017

Overcoming Challenges of Assays of Complex Cellular Models with Real-Time Live-Cell Analysis

There's a continued drive towards making in vitro assays ever more translational towards in vivo models and ultimately the clinic. This ties in with the resurgence of phenotypic screening and is a response to the perceived poor translation of the traditional simple cell-based assays, often developed to study just single protein targets.

From Sartorius 5 Dec 2017

New treatment aims to target abnormally shaped protein in deadly childhood brain cancer

Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against an abnormally shaped protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers.

4 Dec 2017

Research could contribute to development of therapeutic drug and vaccine against malaria

Malaria is one of three major infectious diseases affecting approximately 300 million people every year, accounting for about 500,000 deaths, but effective vaccine development has not been successful.

4 Dec 2017

Fish oil component provides long-term preconditioning protection for vision cells

A team of LSU Health New Orleans scientists discovered that a component of fish oil not only protects cells critical to vision from potentially lethal initial insults, but also from those that occur in the future.

1 Dec 2017

New vaccine technique can effectively combat breast cancer, mice study shows

A new vaccine technique can fight a certain type of breast cancer in mice. So-called HER2-positive breast cancer accounts for between 20 and 30 per cent of all cases of breast cancer in humans.

30 Nov 2017

Altering genetic mutation could enhance FluMist vaccine’s protective effect

Researchers at Johns Hopkins Bloomberg School of Public Health have discovered a genetic mutation in the FluMist intranasal flu vaccine that has the potential to be altered to enhance the vaccine's protective effect.

30 Nov 2017

Experts offer research strategies to yield more protective flu vaccine candidates

In a New England Journal of Medicine perspective, experts from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and the World Health Organization Collaborating Centre for Reference and Research on Influenza in Melbourne discuss how the process of preparing seasonal influenza vaccines in eggs may contribute to their limited effectiveness.

30 Nov 2017

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

A decade of data on hundreds of boys and girls who received the HPV vaccine indicates the vaccine is safe and effective long term in protecting against the most virulent strains of the virus, researchers report.

29 Nov 2017

University was tipped off to possible unauthorized trials of herpes vaccine

The university that employed a controversial herpes vaccine researcher has told the federal government it learned last summer of the possibility of his illegal experimentation on human subjects.

29 Nov 2017

The ratcheting cost of the pneumococcal vaccine: What gives?

Every November, like clockwork, she gets the same letter, said Dr. Lindsay Irvin, a pediatrician in San Antonio.

29 Nov 2017

WHO delivers medical supplies to tackle outbreak of diphtheria in Yemen

WHO has delivered medicines to tackle an outbreak of diphtheria in Yemen, warning that sustained humanitarian access is critical to stopping its spread.

29 Nov 2017

Researchers tackling deadly TB discuss the way forward in treatment and prevention

Researchers from across the world who are tacking the deadly bacterial disease tuberculosis (TB) attended a symposium at St George's, University of London to discuss the way forward in treatment and prevention.

29 Nov 2017

Immunologist focuses on initial stages of infection to fight against HIV

In a project funded by the Austrian Science Fund FWF, Doris Wilflingseder investigates the initial stages of infection - the time span when the immune system might still stop HIV.

28 Nov 2017

Children should be vaccinated against flu in the run up to Christmas, warns NHS

Children are “super-spreaders” of flu and should be given the flu vaccine to prevent them passing on illness to grandparents and other vulnerable people over the Christmas period, warns the NHS.

27 Nov 2017

Virus Painting, Lipids and Single Particle Charge

Various viral infections still pose a great threat to human and animal health. A wide range of viral species are surrounded by a lipid shell, the envelope, containing viral and cellular proteins.

From Izon Science 27 Nov 2017

Scientists take major step forward in research efforts to develop TB vaccine

A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world's deadliest infectious disease.

25 Nov 2017

Leishmania genome study reveals the parasites adaptation to the environment

A new study, conducted by researchers from the Institut Pasteur in Paris and the Centre for Genomic Regulation (CRG) in Barcelona, have revealed that Leishmania adaptation is a consequence of reversible and frequent chromosomal amplifications.

23 Nov 2017

Vaccine News and Research

Latest Vaccine News and Research

Malaria parasite employs active strategy to deceive the immune system

Investigational ZPIV vaccine found to be safe and immunogenic in trial participants

ICG provides 1.4 million vaccine doses to control yellow fever outbreak in Nigeria

Overcoming Challenges of Assays of Complex Cellular Models with Real-Time Live-Cell Analysis

New treatment aims to target abnormally shaped protein in deadly childhood brain cancer

Research could contribute to development of therapeutic drug and vaccine against malaria

Fish oil component provides long-term preconditioning protection for vision cells

New vaccine technique can effectively combat breast cancer, mice study shows

Altering genetic mutation could enhance FluMist vaccine’s protective effect

Experts offer research strategies to yield more protective flu vaccine candidates

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

University was tipped off to possible unauthorized trials of herpes vaccine

The ratcheting cost of the pneumococcal vaccine: What gives?

WHO delivers medical supplies to tackle outbreak of diphtheria in Yemen

Researchers tackling deadly TB discuss the way forward in treatment and prevention

Immunologist focuses on initial stages of infection to fight against HIV

Children should be vaccinated against flu in the run up to Christmas, warns NHS

Virus Painting, Lipids and Single Particle Charge

Scientists take major step forward in research efforts to develop TB vaccine

Leishmania genome study reveals the parasites adaptation to the environment

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in